Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 307576, 7 pages
http://dx.doi.org/10.1155/2015/307576
Clinical Study

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer

1Division of Hematology and Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan
2Faculty of Medicine, National Yang Ming University, Taipei, Taiwan
3Program in Molecular Medicine, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan
4Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan
5Department of Medicine, Taipei City Hospital, Yang-Ming Branch, Taipei, Taiwan
6Department of Oncology Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
7Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan
8Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan

Received 4 September 2014; Revised 13 November 2014; Accepted 14 November 2014

Academic Editor: Yun Yen

Copyright © 2015 Hsueh-Ju Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Cooper, T. F. Pajak, A. A. Forastiere et al., “Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck,” The New England Journal of Medicine, vol. 350, no. 19, pp. 1937–2019, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Bernier, C. Domenge, M. Ozsahin et al., “Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer,” The New England Journal of Medicine, vol. 350, no. 19, pp. 1945–1952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Bernier and J. S. Cooper, “Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?” Oncologist, vol. 10, no. 3, pp. 215–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Bernier, J. B. Vermorken, and W. M. Koch, “Adjuvant therapy in patients with resected poor-risk head and neck cancer,” Journal of Clinical Oncology, vol. 24, no. 17, pp. 2629–2635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. T. C. Chan, S. F. Leung, R. K. C. Ngan et al., “Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma,” Journal of the National Cancer Institute, vol. 97, no. 7, pp. 536–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Fesneau, Y. Pointreau, S. Chapet et al., “Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study,” International Journal of Radiation Oncology, Biology, Physics, vol. 76, no. 1, pp. 154–163, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. M.-H. Chang, P.-M. Chen, P.-Y. Chu et al., “Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study,” Cancer Chemotherapy and Pharmacology, vol. 63, no. 1, pp. 9–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. L. Tsai, P. Y. Chu, S. K. Tai et al., “Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma,” Japanese Journal of Clinical Oncology, vol. 41, no. 10, pp. 1182–1193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Garden, J. Harris, E. E. Vokes et al., “Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck,” Journal of Clinical Oncology, vol. 22, no. 14, pp. 2856–2864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-M. Bachaud, E. Cohen-Jonathan, C. Alzieu, J.-M. David, E. Serrano, and N. Daly-Schveitzer, “Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial,” International Journal of Radiation Oncology, Biology, Physics, vol. 36, no. 5, pp. 999–1004, 1996. View at Publisher · View at Google Scholar · View at Scopus
  11. J. K. Salama, T. Y. Seiwert, and E. E. Vokes, “Chemoradiotherapy for locally advanced head and neck cancer,” Journal of Clinical Oncology, vol. 25, no. 26, pp. 4118–4126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Šmid, M. Budihna, B. Zakotnik et al., “Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 56, no. 4, pp. 1055–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Ho, R. Pazdur, W. Covington et al., “Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′- tetrahydrofuryl)-5-fluorouracil,” Clinical Cancer Research, vol. 4, no. 9, pp. 2085–2088, 1998. View at Google Scholar · View at Scopus
  14. T. Nakayama and S. Noguchi, “Therapeutic usefulness of postoperative adjuvant chemotherapy with tegafur-uracil (UFT) in patients with breast cancer: focus on the results of clinical studies in Japan,” Oncologist, vol. 15, no. 1, pp. 26–36, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. H. Hu, L. W. Wang, H. J. Lu et al., “Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment,” BioMed Research International, vol. 2014, Article ID 904341, 7 pages, 2014. View at Publisher · View at Google Scholar
  16. Y.-W. Chen, S.-Y. Kao, and M.-H. Yang, “Analysis of p16INK4A expression of oral squamous cell carcinomas in Taiwan: Prognostic correlation without relevance to betel quid consumption,” Journal of Surgical Oncology, vol. 106, no. 2, pp. 149–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Lassen, J. G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard, “Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck,” Journal of Clinical Oncology, vol. 27, no. 12, pp. 1992–1998, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Trotti, A. D. Colevas, A. Setser et al., “CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment,” Seminars in Radiation Oncology, vol. 13, no. 3, pp. 176–181, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Deno, M. Tashiro, M. Miyashita et al., “The mediating effects of social support and self-efficacy on the relationship between social distress and emotional distress in head and neck cancer outpatients with facial disfigurement,” Psycho-Oncology, vol. 21, no. 2, pp. 144–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Singer, O. Krauss, J. Keszte et al., “Predictors of emotional distress in patients with head and neck cancer,” Head & Neck, vol. 34, no. 2, pp. 180–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. B. H. Lue, T. S. Huang, and H. J. Chen, “Physical distress, emotional status, and quality of life in patients with nasopharyngeal cancer complicated by post-radiotherapy endocrinopathy,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 1, pp. 28–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Q. Rogers, K. Rao, J. Malone et al., “Factors associated with quality of life in outpatients with head and neck cancer 6 months after diagnosis,” Head and Neck, vol. 31, no. 9, pp. 1207–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. M. Hansen, P. A. Higgins, C. B. Warner, and M. M. Mayo, “Exploring family relationships through associations of comfort, relatedness states, and life closure in hospice patients: a pilot study,” Palliative and Supportive Care, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Pituskin, A. Fairchild, J. Dutka et al., “Multidisciplinary team contributions within a dedicated outpatient palliative radiotherapy clinic: a prospective descriptive study,” International Journal of Radiation Oncology Biology Physics, vol. 78, no. 2, pp. 527–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. E. E. Vokes, R. L. Schilsky, K. E. Choi et al., “A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer,” Cancer, vol. 63, no. 1, pp. 30–36, 1989. View at Publisher · View at Google Scholar · View at Scopus
  26. D. J. Adelstein, J. P. Saxton, L. A. Rybicki et al., “Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution,” Journal of Clinical Oncology, vol. 24, no. 7, pp. 1064–1071, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Y. Seiwert, J. K. Salama, and E. E. Vokes, “The chemoradiation paradigm in head and neck cancer,” Nature Clinical Practice Oncology, vol. 4, no. 3, pp. 156–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. de la Torre, M. I. García-Berrocal, F. Arias et al., “Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil a nd leucovorin,” International Journal of Radiation Oncology Biology Physics, vol. 70, no. 1, pp. 102–110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Sugawara, M. Maemondo, M. Tachihara et al., “Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601,” Lung Cancer, vol. 81, no. 1, pp. 91–96, 2013. View at Publisher · View at Google Scholar · View at Scopus